Accordingly, these variation sites along the HLA-G gene have been reported in pre-eclampsia [24], cancer [25,26], transplants [27], and autoimmune [28,29], chronic inflammatory [30], and infectious disorders [31,32]. This evidence concerns the gene HLA-G and cancer.